{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Yi Fang"}, {"accession": "MS:1000589", "name": "contact email", "value": "fangyi.cicams@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Chinese Academy of Medical Sciences and Peking Union Medical College"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Jing Wang"}, {"accession": "MS:1000589", "name": "contact email", "value": "wangjing.cicams@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Department of breast surgical oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_Proteome_1.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_Proteome_2.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_Proteome_3.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_Proteome_4.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_Proteome_5.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_Proteome_6.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_1.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_10.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_11.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_12.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_2.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_3.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_4.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_5.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_6.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_7.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_8.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/Genistein_TiO2_9.raw"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/MaxQuantOutput.tar.gz"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/ST1.xlsx"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/ST2.xlsx"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/ST3.xlsx"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735/ST4.xlsx"}], "description": "Around one sixth of breast cancer cases are classified as triple-negative breast cancer (TNBC), named after the absence of the expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2); however, patients with TNBC suffer from poor clinical outcome and shortage of targeted therapy. Genistein, an estrogenic soy isoflavone, shows anti-cancer effects in TNBC cells such as inducing G2/M cell cycle arrest and apoptosis. However, the underlying mechanism of its anti-cancer effects is poorly understood and its elucidation can help the development of novel therapeutic strategies for TNBC. In this study, by combining isobaric tag-based TMT labeling with titanium dioxide-based phosphopeptide enrichment, we quantitated 5,445 phosphorylation sites on 2,008 phosphoproteins in a TNBC cell line, MDA-MB-231, upon genistein treatment. Our analysis revealed 332 genistein-regulated phosphorylation sites on 226 proteins. Our data show that genistein can regulate several biological processes during the cell cycle, including DNA replication, cohesin complex cleavage, and kinetochore formation. In the meantime, genistein can also activate DNA damage response, including activation of ATR and BRCA1 complex. Overall, for the first time, our study present the evidence that genistein could inhibit TNBC cell growth by regulating the cell cycle and DNA damage response. Our findings help elucidate the mechanisms through which genistein exerts its anti-cancer effects in TNBC cells.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002735"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD002735"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD002735"}], "instruments": [{"accession": "MS:1001742", "name": "LTQ Orbitrap Velos"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Genistein, MDA-MB-231, Triple Negative Breast Cancer, ATR, CKD1, LC-MS/MS, Phosphorylation"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}, {"accession": "MOD:00696", "name": "phosphorylated residue"}, {"accession": "MOD:01720", "name": "TMT6plex-126 reporter+balance reagent acylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "26783066"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Fang Y, Zhang Q, Wang X, Yang X, Wang X, Huang Z, Jiao Y, Wang J. Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells. Int J Oncol. 2016 Jan 11"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Quantitative Phosphoproteomics Reveals Genistein as a Modulator of Cell Cycle and DNA Damage Response Pathways"}